Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1234 4 |
Ultima descărcare din IBN: 2023-09-12 13:15 |
SM ISO690:2012 TOFAN, Elena, GONCIAR, Veaceslav, БУТОРОВ, Иван, NECULA, Gheorghe, КОЩУГ, Ион. Сравнительная эффективность лозартана и лизиноприла в терапии хронической сердечной недостаточности. In: Curierul Medical, 2010, nr. 5(317), pp. 15-19. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | ||||||
Numărul 5(317) / 2010 / ISSN 1875-0666 | ||||||
|
||||||
Pag. 15-19 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
E. Tofan, V. Gonciar, I. Butorov, G. Necula, I. Cosciug
Comparative Efficiency of Losartan and Lisinopril in the Treatment of Chronic Heart Failure
The aim of the work was to appreciate the influence of the antagonist of AT I receptors Losartan on the hemodynamics and morphofunctional
parameters of the heart. Were examined 50 patients with chronic heart failure (CHF) of III functional class (FC) and the ejection fraction of
the left ventricle (L. V) less then 45%, with average age – 62.1 ± 2.4 years old. All patients formed 2 groups: patients from the 1st group (n = 25)
took 50 mg of Losartan once in 24 hours, the 2nd (n = 25) – Lisinopril 10 mg. The treatment lasted 24 weeks. By the results of the study, it was
established that Losartan provoked a more efficient diminishing of the clinical symptoms of CHF in comparison with Lisinopril, the diminishing
of the left atrium and ventricle in size and contractility enhancement of the left ventricle. |
||||||
Cuvinte-cheie chronic heart failure, Losartan, myocardium remodeling, Lisinopril |
||||||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Tofan, E.</dc:creator> <dc:creator>Gonciar, V.I.</dc:creator> <dc:creator>Butorov, I.V.</dc:creator> <dc:creator>Necula, G.</dc:creator> <dc:creator>Coşciug, I.V.</dc:creator> <dc:date>2010-09-06</dc:date> <dc:description xml:lang='en'>E. Tofan, V. Gonciar, I. Butorov, G. Necula, I. Cosciug Comparative Efficiency of Losartan and Lisinopril in the Treatment of Chronic Heart Failure The aim of the work was to appreciate the influence of the antagonist of AT I receptors Losartan on the hemodynamics and morphofunctional parameters of the heart. Were examined 50 patients with chronic heart failure (CHF) of III functional class (FC) and the ejection fraction of the left ventricle (L. V) less then 45%, with average age – 62.1 ± 2.4 years old. All patients formed 2 groups: patients from the 1st group (n = 25) took 50 mg of Losartan once in 24 hours, the 2nd (n = 25) – Lisinopril 10 mg. The treatment lasted 24 weeks. By the results of the study, it was established that Losartan provoked a more efficient diminishing of the clinical symptoms of CHF in comparison with Lisinopril, the diminishing of the left atrium and ventricle in size and contractility enhancement of the left ventricle.</dc:description> <dc:description xml:lang='ru'>Целью работы было изучение влияния антагониста рецепторов АТ-I Лозартана с гемодинамическими и морфофункциональными параметрами сердца. Было исследовано 50 пациентов с хронической сердечной недостаточностью (ХСН) III стадии и выбросом левого желудочка меньше 45%, средний возраст – 62,1 ± 2,4 года. Все пациенты были разделены на две группы: пациенты первой группы (25 больных) получали 50 мг Лозартана однократно в 24 часа, пациенты второй группы (25 больных) – Лизиноприл 10 мг. Наблюдение проводилось 24 недели. Соответственно полученным результатам было установлено, что лозартан в большей степени провоцирует эффективное уменьшение клинических симптомов ХСН по сравнению с лизиноприлом, уменьшает размер левых камер сердца и улучшает функцию левого желудочка.</dc:description> <dc:source>Curierul Medical 317 (5) 15-19</dc:source> <dc:subject>chronic heart failure</dc:subject> <dc:subject>Losartan</dc:subject> <dc:subject>myocardium remodeling</dc:subject> <dc:subject>Lisinopril</dc:subject> <dc:title>Сравнительная эффективность лозартана и лизиноприла в терапии хронической сердечной недостаточности</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>